Peter Rhode is listed as an executive officer on 17 SEC Form D filings by 2 issuers between Oct 2009 and Oct 2026: Altor Bioscience Corp (Miramar, FL — biotechnology — 2009–2017; $30.3M reported sold to 29 investors) and HCW Biologics Inc. (Miramar, FL — biotechnology — 2020–2026; $6.92M reported sold to 9 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 17 years. Across those companies the filings report $37.2M sold in total.
Listed alongside Hing C. Wong (17 shared filings), Fred Middleton (12 shared filings), C. Boyden Gray (9 shared filings), Rick S. Greene (7 shared filings), Bee-Yau Huang (6 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 4 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 17 public filings for Peter Rhode and found 10 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.